Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)

Mohamed Bouchahda, Ayhan Ulusakarya, Anne Thirot-Bidault, Amal Attari, Rachel Bossevot, Richard Tuligenga, Pascal Hammel, René Adam, Francis Levi

Open source

DOI
10.1136/bmjopen-2022-069973
Published
2023-06
Container
BMJ Open
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2022-069973,
  title = {Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)},
  author = {Mohamed Bouchahda and Ayhan Ulusakarya and Anne Thirot-Bidault and Amal Attari and Rachel Bossevot and Richard Tuligenga and Pascal Hammel and René Adam and Francis Levi},
  year = {2023},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2022-069973},
  url = {https://doi.org/10.1136/bmjopen-2022-069973}
}

RIS

TY  - JOUR
TI  - Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
AU  - Mohamed Bouchahda
AU  - Ayhan Ulusakarya
AU  - Anne Thirot-Bidault
AU  - Amal Attari
AU  - Rachel Bossevot
AU  - Richard Tuligenga
AU  - Pascal Hammel
AU  - René Adam
AU  - Francis Levi
PY  - 2023
JO  - BMJ Open
DO  - 10.1136/bmjopen-2022-069973
UR  - https://doi.org/10.1136/bmjopen-2022-069973
ER  - 

APA

Bouchahda, M., Ulusakarya, A., Thirot-Bidault, A., Attari, A., Bossevot, R., Tuligenga, R., Hammel, P., Adam, R., & Levi, F. (2023). Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948). BMJ Open. https://doi.org/10.1136/bmjopen-2022-069973

Source records